AI-guided personalized drug combinations to treat relapsed lymphoma
MedicalXpress Breaking News-and-Events | Dec 20, 2022
Acute myeloid leukemia: Germany-wide clinical trial challenges international standard of care
MedicalXpress Breaking News-and-Events | Dec 14, 2022
Clinical trial leads to a decrease in early deaths from rare and aggressive acute promyelocytic leukemia (APL)
MedicalXpress Breaking News-and-Events | Dec 13, 2022
Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial shows
MedicalXpress Breaking News-and-Events | Dec 12, 2022
How 'chameleon cancers' can change their colors to survive treatment
MedicalXpress Breaking News-and-Events | Nov 02, 2022
Children with resistant leukemia given CRISPR-edited T cells: Phase 1 study results reported
MedicalXpress Breaking News-and-Events | Nov 01, 2022
A new treatment for acute myeloid leukemia could prove beneficial for even more people
MedicalXpress Breaking News-and-Events | Sep 17, 2022
Improving drug therapy for relapsed leukemia
MedicalXpress Breaking News-and-Events | Sep 16, 2022
Researchers identify a new class of drugs that offer a safer, more targeted treatment for leukemia patients
ScienceDaily | Aug 27, 2022
New study indicates people with current cancer diagnosis may face severe complications from COVID-19
MedicalXpress Breaking News-and-Events | Aug 18, 2022